Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11857574
Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11857535
Methods of treating mutant lymphomas
granted -
US 11857697
Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof
granted -
US 11857613
Vaccine for prevention of necrotic enteritis in poultry
granted -
US 11857641
Method for the treatment of mucopolysaccharidosis type I
granted -
US 11859234
Method of monitoring RNase L activity
granted -
US 11859185
Glucokinase (GCK) iRNA compositions and methods of use thereof
granted -
US 11859021
Compounds for regulating trained immunity, and their methods of use
granted -
US 11857647
Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
granted -
US 11859016
Peptide having cytoprotective effect against environmental pollutant and use thereof
granted -
US 11859180
Antisense oligonucleotide compositions
granted -
US 11858970
Chili pepper seed isolated oligopeptide FTLE and application thereof in preventing or treating cancer
granted -
US 11858953
Compositions and methods for synthesis of phosphorylated molecules
granted -
US 11859007
Humanized anti-CD73 antibodies
granted -
US 11859000
Anti-CCR8 antibodies and uses thereof
granted -
US 11858957
Ectonucleotidase inhibitors and methods of use thereof
granted -
US 11858931
Amino acid compounds with unbranched linkers and methods of use
granted -
US 11857651
Compositions with doped titanium dioxide nanoparticles and methods of use
granted -
US 11858932
Methods and compositions for treating polycystic ovary syndrome
granted -
US 11858941
Heterocyclic and heteroaryl compounds for treating Huntington's disease
granted -
US 11858937
Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
granted -
US 11858930
Fused bicyclic RAF inhibitors and methods for use thereof
granted -
US 11857608
Dosage forms of tissue kallikrein 1
granted -
US 11858913
Bicyclic pyridazinones and methods of use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.